search
Back to results

Predictive Monitoring - IMPact in Acute Care Cardiology Trial (PM-IMPACCT)

Primary Purpose

Clinical Deterioration

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CoMET Display
Sponsored by
Jamieson Bourque, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Clinical Deterioration

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Assigned for clinical purposes to a beds which is part of a randomized cluster

Exclusion Criteria:

  • none

Sites / Locations

  • University of Virginia Health System

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

CoMET Display

No Display

Arm Description

Display of Continuous Monitoring of Event Trajectories (CoMET) predictive monitoring score, with standard CoMET device training.Risk scores will also be presented daily during rounds to members of the care team.

Standard CoMET device training but no display or presentation of predictive monitoring score.

Outcomes

Primary Outcome Measures

Hours free of events of clinical deterioration
(1) The number of hours free of acute clinical events within 21 day of admission. Hours of acute clinical events are defined as time when one or more of the following occur: An emergent ICU transfer (emergent defined as urgent, unplanned) and ICU stay Emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) Cardiac arrest, if prior to ICU transfer or death Death A maximum score will be 21 event-free days (504 hours). Patients who are discharged from the hospital prior to 21 days without an event will be counted as having 21 event-free days. Patients who die during the admission will be counted as having 0 event-free days. Patients will be censored (with no event observed) at the time of non-emergent ICU transfer, surgery transfer, or other transfer.

Secondary Outcome Measures

Hours to proactive clinical response
We will use a Kaplan Meier or Cox Proportional Hazard Curve to determine differences in response time between display and control. Time to the 1st order for transfusion of 3 units or more of blood ordered within 24 hours Time to first order for IV inotropes or pressors administered Time to first order for blood or urine culture obtained for suspicion of infection Time to first order for lactate drawn Time to first order for antibiotics given for suspicion of infection Time to first order for fluid resuscitation given for suspicion of shock Time to rapid response team (RRT or MET) call initiation.
Subgroup secondary outcome: post-ICU transfer event-free survival
A subgroup secondary outcome will be a Kaplan Meier or Cox Proportional Hazard curve showing post-ICU transfer, event-free survival, hours free of the following events: Time of emergent intubation post-ICU transfer (emergent is defined by clinician's notes as a non-planned procedure) Time of the 1st order post-ICU transfer for transfusion of 3 units or more of blood ordered within 24 hours Time of first order post-ICU transfer of IV inotropes or pressors Time of cardiac arrest post-ICU transfer Time of CHF escalation, defined by the time of first order for diuretic drip, time of first order for CVVHD, or time of dialysis initiation Time of death post-ICU transfer Discharge from the ICU without an event will count as "infinite" event-free survival.
Proportion of Emergent ICU transfer at any point in the hospital stay
Proportion of patients experiencing emergent ICU transfer (emergent defined as urgent, unplanned) at any point in the hospital stay after admission to the fourth floor:
Proportion of emergent intubation at any point in the hospital stay
Proportion of patients experiencing emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) at any point in the hospital stay after admission to the fourth floor
Proportion of 3 units or more of blood ordered in 24 hours at any point in the hospital stay
Proportion of patients with 3 units or more of blood ordered in 24 hours at any point in the hospital stay after admission to the fourth floor
Proportion of IV inotropes or pressors at any point in the hospital stay
Proportion of patients receiving IV inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Proportions of Shock requiring inotropes or pressors at any point in the hospital stay
Proportions of patients with shock requiring inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Proportion of Sepsis 2 criteria at any point in the hospital stay
Proportion of patients meeting Sepsis 2 criteria at any point in the hospital stay after admission to the fourth floor
Proportion of septic shock at any point in the hospital stay
Proportion of patients with septic shock requiring inotropes or pressors (defined by a combination of Outcome 8 and 9) at any point in the hospital stay after admission to the fourth floor
Proportion of Cardiac arrest at any point in the hospital stay
Proportion of patients experiencing cardiac arrest at any point in the hospital stay after admission to the fourth floor
Proportion of death at any point in the hospital stay
Proportion of patients experiencing death at any point in the hospital stay after admission to the fourth floor
Proportion of Congestive heart failure at any point in the hospital stay
Proportion of patients receiving diuretic drip indicating Congestive Heart Failure escalation at any point in the hospital stay after admission to the fourth floor
Proportion of Inotropes or pressors for refractory heart failure at any point in the hospital
Proportion patients receiving inotropes or pressors for refractory heart failure at any point in the hospital stay after admission to the fourth floor
Hospital length of stay
Hospital length of stay
Length of stay on floor
In patients who are never transferred to the ICU, the length of stay on the floor.
ICU length of stay
ICU length of stay
Hospital readmission
Readmission to hospital within 72 hours post-discharge
Shock in sepsis
In patients who meet the Sepsis 2 criteria, the proportion of Shock, i.e. Hypotension requiring inotropes or pressors
Death in sepsis
In patients who meet the Sepsis 2 criteria, the proportion of death
Cost of Care
Observed:Expected ratio
Number of days on IV antibiotics
Number of days on IV antibiotics
duration of mechanical intubation
Total duration of mechanical intubation (emergent and non-emergent)

Full Information

First Posted
March 20, 2020
Last Updated
November 16, 2022
Sponsor
Jamieson Bourque, MD
Collaborators
Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04359641
Brief Title
Predictive Monitoring - IMPact in Acute Care Cardiology Trial
Acronym
PM-IMPACCT
Official Title
Predictive Monitoring - IMPact in Acute Care Cardiology Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
November 3, 2022 (Actual)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jamieson Bourque, MD
Collaborators
Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Hypothesis: display of predictive analytics monitoring on acute care cardiology wards improves patient outcomes and is cost-effective to the health system. The investigators have developed and validated computational models for predicting key outcomes in adults, and a useful display has been developed, implemented and iteratively optimized. These models estimate risk of imminent patient deterioration using trends in vital signs, labs and cardiorespiratory dynamics derived from readily available continuous bedside monitoring. They are presented on LCD monitors using software called CoMET (Continuous Monitoring of Event Trajectories; AMP3D, Advanced Medical Predictive Devices, Diagnostics, and Displays, Charlottesville, VA) To test the impact on patient outcomes, the investigators propose a 22-month cluster-randomized control trial on the 4th floor of UVa Hospital, a medical-surgical floor for cardiology and cardiovascular surgery patients. Clinicians will receive standard CoMET device training. Three- to five-bed clusters will be randomized to intervention (predictive display plus standard monitoring) or control (standard monitoring alone) for two months at a time. In addition, risk scores for patients in the intervention clusters will be presented daily during rounds to members of the care team of physicians, residents, nurses, and other clinicians. Data on outcomes will be statistically compared between intervention and control clusters.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Clinical Deterioration

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10424 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CoMET Display
Arm Type
Experimental
Arm Description
Display of Continuous Monitoring of Event Trajectories (CoMET) predictive monitoring score, with standard CoMET device training.Risk scores will also be presented daily during rounds to members of the care team.
Arm Title
No Display
Arm Type
No Intervention
Arm Description
Standard CoMET device training but no display or presentation of predictive monitoring score.
Intervention Type
Device
Intervention Name(s)
CoMET Display
Intervention Description
Display and presentation of predictive monitoring score CoMET
Primary Outcome Measure Information:
Title
Hours free of events of clinical deterioration
Description
(1) The number of hours free of acute clinical events within 21 day of admission. Hours of acute clinical events are defined as time when one or more of the following occur: An emergent ICU transfer (emergent defined as urgent, unplanned) and ICU stay Emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) Cardiac arrest, if prior to ICU transfer or death Death A maximum score will be 21 event-free days (504 hours). Patients who are discharged from the hospital prior to 21 days without an event will be counted as having 21 event-free days. Patients who die during the admission will be counted as having 0 event-free days. Patients will be censored (with no event observed) at the time of non-emergent ICU transfer, surgery transfer, or other transfer.
Time Frame
within 21 days of the admission
Secondary Outcome Measure Information:
Title
Hours to proactive clinical response
Description
We will use a Kaplan Meier or Cox Proportional Hazard Curve to determine differences in response time between display and control. Time to the 1st order for transfusion of 3 units or more of blood ordered within 24 hours Time to first order for IV inotropes or pressors administered Time to first order for blood or urine culture obtained for suspicion of infection Time to first order for lactate drawn Time to first order for antibiotics given for suspicion of infection Time to first order for fluid resuscitation given for suspicion of shock Time to rapid response team (RRT or MET) call initiation.
Time Frame
through study completion, on average one week
Title
Subgroup secondary outcome: post-ICU transfer event-free survival
Description
A subgroup secondary outcome will be a Kaplan Meier or Cox Proportional Hazard curve showing post-ICU transfer, event-free survival, hours free of the following events: Time of emergent intubation post-ICU transfer (emergent is defined by clinician's notes as a non-planned procedure) Time of the 1st order post-ICU transfer for transfusion of 3 units or more of blood ordered within 24 hours Time of first order post-ICU transfer of IV inotropes or pressors Time of cardiac arrest post-ICU transfer Time of CHF escalation, defined by the time of first order for diuretic drip, time of first order for CVVHD, or time of dialysis initiation Time of death post-ICU transfer Discharge from the ICU without an event will count as "infinite" event-free survival.
Time Frame
through study completion, on average one week
Title
Proportion of Emergent ICU transfer at any point in the hospital stay
Description
Proportion of patients experiencing emergent ICU transfer (emergent defined as urgent, unplanned) at any point in the hospital stay after admission to the fourth floor:
Time Frame
through study completion, on average one week
Title
Proportion of emergent intubation at any point in the hospital stay
Description
Proportion of patients experiencing emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of 3 units or more of blood ordered in 24 hours at any point in the hospital stay
Description
Proportion of patients with 3 units or more of blood ordered in 24 hours at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of IV inotropes or pressors at any point in the hospital stay
Description
Proportion of patients receiving IV inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportions of Shock requiring inotropes or pressors at any point in the hospital stay
Description
Proportions of patients with shock requiring inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of Sepsis 2 criteria at any point in the hospital stay
Description
Proportion of patients meeting Sepsis 2 criteria at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of septic shock at any point in the hospital stay
Description
Proportion of patients with septic shock requiring inotropes or pressors (defined by a combination of Outcome 8 and 9) at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of Cardiac arrest at any point in the hospital stay
Description
Proportion of patients experiencing cardiac arrest at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of death at any point in the hospital stay
Description
Proportion of patients experiencing death at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of Congestive heart failure at any point in the hospital stay
Description
Proportion of patients receiving diuretic drip indicating Congestive Heart Failure escalation at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Proportion of Inotropes or pressors for refractory heart failure at any point in the hospital
Description
Proportion patients receiving inotropes or pressors for refractory heart failure at any point in the hospital stay after admission to the fourth floor
Time Frame
through study completion, on average one week
Title
Hospital length of stay
Description
Hospital length of stay
Time Frame
through study completion, on average one week
Title
Length of stay on floor
Description
In patients who are never transferred to the ICU, the length of stay on the floor.
Time Frame
through study completion, on average one week
Title
ICU length of stay
Description
ICU length of stay
Time Frame
through study completion, on average one week
Title
Hospital readmission
Description
Readmission to hospital within 72 hours post-discharge
Time Frame
within 72 hours post-discharge
Title
Shock in sepsis
Description
In patients who meet the Sepsis 2 criteria, the proportion of Shock, i.e. Hypotension requiring inotropes or pressors
Time Frame
through study completion, on average one week
Title
Death in sepsis
Description
In patients who meet the Sepsis 2 criteria, the proportion of death
Time Frame
through study completion, on average one week
Title
Cost of Care
Description
Observed:Expected ratio
Time Frame
through study completion, on average one week
Title
Number of days on IV antibiotics
Description
Number of days on IV antibiotics
Time Frame
through study completion, on average one week
Title
duration of mechanical intubation
Description
Total duration of mechanical intubation (emergent and non-emergent)
Time Frame
through study completion, on average one week

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Assigned for clinical purposes to a beds which is part of a randomized cluster Exclusion Criteria: none
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jamieson M Bourque, MD
Organizational Affiliation
University of Virginia Health System
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Virginia Health System
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22908
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34043525
Citation
Keim-Malpass J, Ratcliffe SJ, Moorman LP, Clark MT, Krahn KN, Monfredi OJ, Hamil S, Yousefvand G, Moorman JR, Bourque JM. Predictive Monitoring-Impact in Acute Care Cardiology Trial (PM-IMPACCT): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Jul 2;10(7):e29631. doi: 10.2196/29631.
Results Reference
derived

Learn more about this trial

Predictive Monitoring - IMPact in Acute Care Cardiology Trial

We'll reach out to this number within 24 hrs